View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Korro to Host Virtual Analyst Day on January 27, 2026

Korro to Host Virtual Analyst Day on January 27, 2026 - Program to feature presentations from the company management about KRRO-121 for the potential treatment of hyperammonemia, a leading clinical hepatologist about ammonia-driven diseases, and a caregiver sharing perspectives on living with urea cycle disorder - CAMBRIDGE, Mass., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that the company will host a virtual Analyst Day on Tuesday, January 27, 2026, from 8 a.m. – 10 a.m. ET, with members of the Korro management team, Bruce Scharschmidt, MD,...

 PRESS RELEASE

Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference

Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference CAMBRIDGE, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that Ram Aiyar, Ph.D., Chief Executive Officer and President, will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2026, at 10:30 a.m. PT (1:30 p.m. ET). Todd Chappell, Chief Operating Officer, and Loic Vincent, Ph.D., Chief Scientific Officer, will also be participating at the conference. A live webcast of the presentation can be accessed on the “Events & Presentations” page ...

 PRESS RELEASE

The Lovesac Company Announces Participation in the 2026 ICR Conference

The Lovesac Company Announces Participation in the 2026 ICR Conference STAMFORD, Conn., Jan. 05, 2026 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, announced today that the Company is scheduled to participate in the 2026 ICR Conference on Monday, January 12, 2026, at 11:00 a.m. Eastern Time. The fireside chat will be webcast live over the Internet and can be accessed on the Company’s Investor Relations website, investor.lovesac.com. An on...

 PRESS RELEASE

The Lovesac Company Publishes 2025 ESG Report

The Lovesac Company Publishes 2025 ESG Report STAMFORD, Conn., Dec. 19, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) ("Lovesac" or the "Company"), the Designed for Life home and technology brand, has released its ESG & Impact Report for the 2025 fiscal year ended February 2, 2025. This report highlights the company's continued focus on environmental sustainability, social responsibility, and governance (“ESG”). Shawn Nelson, Chief Executive Officer, stated, "Our 2025 ESG report reflects the maturation of our sustainability journey and our deepening accountability to creati...

 PRESS RELEASE

The Lovesac Company Reports Third Quarter Fiscal 2026 Financial Result...

The Lovesac Company Reports Third Quarter Fiscal 2026 Financial Results Q3 FY26 Net Sales Increased 0.2% to $150.2 Million vs. Q3 FY25 STAMFORD, Conn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced financial results for the third quarter of fiscal 2026, which ended November 2, 2025. Shawn Nelson, Chief Executive Officer, stated, “Our focus on secular growth initiatives such as new products and the beginni...

Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: December 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

The Lovesac Company Announces Third Quarter Conference Call Date

The Lovesac Company Announces Third Quarter Conference Call Date STAMFORD, Conn., Nov. 26, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand, today announced that its third quarter financial results will be released before market open on Thursday, December 11, 2025. The Company will host a conference call at 8:30 a.m. Eastern Time to discuss the financial results. Investors and analysts interested in participating in the call are invited to dial 877-407-3982 (international callers please dial 201-493-...

 PRESS RELEASE

The Lovesac Company Appoints Wan Ling Martello to Its Board of Directo...

The Lovesac Company Appoints Wan Ling Martello to Its Board of Directors STAMFORD, Conn., Nov. 20, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced that Wan Ling Martello has been appointed to the Board of Directors, effective November 20, 2025. Andrew Heyer, Chairman of the Board of Directors, stated, “We are delighted to welcome Wan Ling to our Board of Directors. Her exceptional track record of driving transformationa...

 PRESS RELEASE

Korro Reports Third Quarter Financial Results, Provides Updates on KRR...

Korro Reports Third Quarter Financial Results, Provides Updates on KRRO-110 in Alpha-1 Antitrypsin Deficiency and Additional Pipeline Programs CAMBRIDGE, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- —KRRO-110 produced functional protein in Alpha-1 Antitrypsin Deficiency (AATD) patients  —KRRO-110 did not reach projected levels of functional protein following a single administration    —Pivoting to GalNAc delivery for patients with AATD; development candidate nomination expected in the first half of 2026  —Nominated KRRO-121, designed to create a de novo protein variant to activate a biologica...

 PRESS RELEASE

The Lovesac Company Appoints Jacob Pat as Chief Technology and Digital...

The Lovesac Company Appoints Jacob Pat as Chief Technology and Digital Transformation Officer Proven Technology Leader to Enhance the Company’s Digital Strategies to Support Growth Objectives STAMFORD, Conn., Oct. 21, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced the appointment of Jacob Pat as Chief Technology and Digital Transformation Officer effective immediately. Mr. Pat will spearhead Lovesac’s enterprise techn...

 PRESS RELEASE

The Lovesac Company Announces Participation in Upcoming Investor Confe...

The Lovesac Company Announces Participation in Upcoming Investor Conference STAMFORD, Conn., Oct. 01, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, announced today that the Company is scheduled to participate in the 2025 Global Consumer & Retail Conference hosted by Telsey Advisory Group in collaboration with Santander Corporate & Investment Banking on Wednesday, October 8, 2025, at 3:30 p.m. Eastern Time. The fireside chat will be w...

 PRESS RELEASE

The Lovesac Company Reports Second Quarter Fiscal 2026 Financial Resul...

The Lovesac Company Reports Second Quarter Fiscal 2026 Financial Results Q2 FY26 Net Sales Increased 2.5% to $160.5 Million vs. Q2 FY25 STAMFORD, Conn., Sept. 11, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced financial results for the second quarter of fiscal 2026, which ended August 3, 2025. Shawn Nelson, Chief Executive Officer, stated, “We're pleased to have delivered another quarter of market share gains under...

 PRESS RELEASE

Korro to Participate in Upcoming Investor and Scientific Conferences

Korro to Participate in Upcoming Investor and Scientific Conferences CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor and scientific conferences for the month of September: Citi's 2025 Biopharma Back to School ConferenceRam Aiyar, Ph.D., Chief Executive Officer and President, and Loic Vincent, Ph.D., Chief Scientific Officer, will participate in 1x1 investor meetings on Wednesday, September 3, 2025. Cantor Global Healthcare ConferenceDr. Aiyar will pa...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

The Lovesac Company Announces Second Quarter Conference Call Date

The Lovesac Company Announces Second Quarter Conference Call Date STAMFORD, Conn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand, today announced that its second quarter financial results will be released before market open on Thursday, September 11, 2025. The Company will host a conference call at 8:30 a.m. Eastern Time to discuss the financial results. Investors and analysts interested in participating in the call are invited to dial 877-407-3982 (international callers please dial 201-4...

 PRESS RELEASE

The Lovesac Company Appoints Alan Boehme to Its Board of Directors

The Lovesac Company Appoints Alan Boehme to Its Board of Directors STAMFORD, Conn., Aug. 27, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) ("Lovesac" or the "Company"), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced that Alan Boehme has been appointed to the Board of Directors, effective August 27, 2025. Andrew Heyer, Chairman of the Board of Directors, stated, "We are thrilled to welcome Alan to our Board. His exceptional track record of driving digital transformation, operational excellence,...

 PRESS RELEASE

Korro Reports Second Quarter 2025 Financial Results and Provides Busin...

Korro Reports Second Quarter 2025 Financial Results and Provides Business Updates — Interim readout from Phase 1/2a REWRITE clinical trial of KRRO-110 on track for the second half of 2025 — Completed dosing of over 80% of planned REWRITE healthy volunteers across multiple single ascending dose (SAD) cohorts with no treatment emergent serious adverse events (SAEs) or dose limiting toxicities observed — European Medicines Agency (EMA) granted Orphan Drug Designation to KRRO-110 for the treatment of Alpha-1 Antitrypsin Deficiency (AATD) — Development candidate for Korro’s rare metabolic di...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch